Rchr
J-GLOBAL ID:200901009109582331   Update date: Apr. 25, 2024

Hattori Yasunao

ハットリ ヤスナオ | Hattori Yasunao
Research field  (2): Bioorganic chemistry ,  Pharmaceuticals - chemistry and drug development
Research theme for competitive and other funds  (5):
  • 2021 - 2024 Optimization of SARS 3CL protease inhibitor and development of anti-COVID-19 drug
  • 2017 - 2020 Development of novel therapeutic agents for schizophrenia based on kynurenine hypothesis
  • 2015 - 2017 Development of novel BACE1 inhibitors based on the N-amidino nitrogen-containing ring structure
  • 2013 - 2016 Design of non-peptide inhibitors based on structure analyses of the protease/inhibitor complex
  • 2013 - 2015 Development of novel BACE1 inhibitors: Structure activity relationship study based on the substrate sequence
Papers (76):
  • Chiyuki Awahara, Daiki Oku, Kazuya Kobayashi, Yasunao Hattori. Evaluating a Retro-Inverso Type Inhibitor of HTLV-1 Protease as a Competitive Inhibitor. Chemical & pharmaceutical bulletin. 2024. 72. 3. 309-310
  • Marina Omokawa, Hiroyuki Kimura, Kenji Arimitsu, Yusuke Yagi, Yasunao Hattori, Hidekazu Kawashima, Yuki Naito, Hiroyuki Yasui. Synthesis and Biological Evaluation of a Novel Sugar-Conjugated Platinum(II) Complex Having a Tumor-Targeting Effect. ACS Omega. 2023
  • Yuto Kondo, Hiroyuki Kimura, Minon Sasaki, Sumina Koike, Yusuke Yagi, Yasunao Hattori, Hidekazu Kawashima, Hiroyuki Yasui. Effect of Water on Direct Radioiodination of Small Molecules/Peptides Using Copper-Mediated Iododeboronation in Water-Alcohol Solvent. ACS Omega. 2023
  • Yukie Nohara, Keiko Taniguchi, Hiromi Ii, Shun Masuda, Hiroko Kawakami, Masakatsu Matsumoto, Yasunao Hattori, Susumu Kageyama, Toshiyuki Sakai, Susumu Nakata, et al. Development of an activity-based chemiluminogenic probe for γ-glutamylcyclotransferase. Organic & Biomolecular Chemistry. 2023. 21. 29. 5977-5984
  • Yuki Sugiyama, Seikou Nakamura, Yuichi Tokuda, Masakazu Nakano, Yasunao Hattori, Hiroki Nishiguchi, Yuki Toda, Shigekuni Hosogi, Masayuki Yamashita, Kei Tashiro, et al. 7,8-Dihydroxy-3-(4′-hydroxyphenyl)coumarin inhibits invasion and migration of osteosarcoma cells. Biochemical and Biophysical Research Communications. 2023. 638. 200-209
more...
MISC (21):
more...
Education (3):
  • 2005 - 2008 Shinshu University Interdisciplinary Graduate School of Science and Technology
  • 2001 - 2003 Shinshu University Graduate School, Division of Agriculture
  • 1997 - 2001 Shinshu University Faculty of Agriculture Bioscience and Biotechnology
Work history (4):
  • 2016 - Kyoto Pharmaceutical University Instrumental Analysis Center
  • 2011 - Kyoto Pharmaceutical University
  • 2009 - Kyoto Prefectural University of Medicine Graduate School of Medical Science
  • 2008 - 米国National Institutes of Health, Visiting Fellow
Association Membership(s) (5):
THE JAPANESE CANCER ASSOCIATION ,  The Japanese Peptide Society ,  THE PHARMACEUTICAL SOCIETY OF JAPAN ,  THE SOCIETY OF SYNTHETIC ORGANIC CHEMISTRY, JAPAN ,  JAPAN SOCIETY FOR BIOSCIENCE, BIOTECHNOLOGY, AND AGROCHEMISTRY
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page